{
  "docId": "019de074-ddab-749d-b286-5e01e8bcb935",
  "docSlug": "f43e68719e672319f390e5844d5bc5fe",
  "documentTitle": "Chimerix | Investor Presentation Deck | 41 slides",
  "authorId": "chimerix",
  "authorName": "Chimerix",
  "documentKindSlug": "pitchdeck",
  "documentKindLabel": "Pitch deck",
  "sourceTypeSlug": "investor_relations",
  "sourceTypeLabel": "Investor relations",
  "presentationDate": "2023-05-01 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.7777778,
  "pageNumber": 33,
  "pageCount": 41,
  "prevPage": 32,
  "nextPage": 34,
  "slideType": "traction",
  "function": "show_traction",
  "density": "dense",
  "nDataPoints": 2,
  "notes": "The slide highlights early clinical efficacy data from a dose escalation trial.",
  "elementsJson": null,
  "metadataConfidence": 0.95,
  "imagePath": null,
  "slideHref": "/slides/019de074-ddab-749d-b286-5e01e8bcb935/33",
  "deckHref": "/decks/019de074-ddab-749d-b286-5e01e8bcb935",
  "deckJsonHref": "/decks/019de074-ddab-749d-b286-5e01e8bcb935.json",
  "deckAnchorHref": "/decks/019de074-ddab-749d-b286-5e01e8bcb935#slide-33",
  "components": [
    {
      "bbox": {
        "h": 0.34,
        "w": 0.34,
        "x": 0.54,
        "y": 0.285
      },
      "kind": "image",
      "text": null,
      "attrs": null,
      "subkind": "illustration",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "b7397cba-3c13-406c-a746-9f4e60ba8888",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.1,
        "w": 0.34,
        "x": 0.54,
        "y": 0.67
      },
      "kind": "image",
      "text": "National Institutes of Health, Pacific Pediatric Neuro-Oncology Consortium",
      "attrs": null,
      "subkind": "logo-grid",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "c10a6e54-17ae-4099-bcec-b72a53686521",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.6,
        "w": 0.45,
        "x": 0.06,
        "y": 0.23
      },
      "kind": "list",
      "text": "Monotherapy dose escalation trials enrolling in parallel for adult and pediatric CNS tumors. Response reported by investigator from early cohort (100mg QW) without H3 K27M mutation: 18-year-old patient with recurrent temporal lobe glioblastoma; Regression on MRI & metabolic reduction via PET imaging, continuing on therapy over 10 months; Details to be presented at future medical conference.",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "95c59dc5-28ca-4078-b275-9b6d451408b2",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.05,
        "w": 0.5,
        "x": 0.06,
        "y": 0.06
      },
      "kind": "title",
      "text": "ONC206 dose escalation: pediatric and adult CNS tumors",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "03186901-b947-4238-9814-341d85298584",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [
    {
      "name": "List presentation",
      "slug": "list-presentation",
      "agent": null,
      "layer": "slide",
      "matchId": "c15c5f3e-c3f5-4908-b01f-cc32acaf3877",
      "evidence": "list/bullet: Monotherapy dose escalation trials enrolling in parallel for adult and pediatric CNS tumors.",
      "confidence": 0.9
    }
  ],
  "frameworks": [],
  "arcBeats": [],
  "loops": [],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}